Cargando…
Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas.
Using nucleolar organizer regions (NORs) as a proliferative marker and Bax expression as a marker for apoptosis, we have studied the individual and combined prognostic significance of these markers. Successive sections of diagnostic, formalin-fixed and paraffin-embedded specimens from 69 patients wi...
Autores principales: | , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group|1
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062936/ https://www.ncbi.nlm.nih.gov/pubmed/9662258 |
_version_ | 1782137233082417152 |
---|---|
author | Xie, X. Clausen, O. P. De Angelis, P. Boysen, M. |
author_facet | Xie, X. Clausen, O. P. De Angelis, P. Boysen, M. |
author_sort | Xie, X. |
collection | PubMed |
description | Using nucleolar organizer regions (NORs) as a proliferative marker and Bax expression as a marker for apoptosis, we have studied the individual and combined prognostic significance of these markers. Successive sections of diagnostic, formalin-fixed and paraffin-embedded specimens from 69 patients with T1-4 tumours were stained with a rabbit anti-human Bax polyclonal antibody and silver nitrate for visualization of NORs (AgNORs). After classification for staining intensity and the percentage of Bax expression, a final score resulting in four classes of increasing Bax expression was obtained. AgNOR counts were expressed as mean counts (mAgNOR) and the percentage of tumour nuclei with more than one AgNOR (pAgNOR>1). Both AgNOR parameters were grouped in three classes with increasing values. Low Bax scores correlated significantly with poor prognosis (P = 0.0106). For mAgNOR and pAgNOR>1, high values correlated with poor prognosis (P = 0.0185 and P = 0.0003 respectively). A combined parameter, for which the Bax score was subtracted from the AgNOR scores, appeared to be statistically stronger than the individual parameters (P < 0.0001). Both Bax expression and AgNOR scores, and in particular the combination of these parameters, appear to be strong prognostic markers in glottic squamous cell carcinomas. |
format | Text |
id | pubmed-2062936 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1998 |
publisher | Nature Publishing Group|1 |
record_format | MEDLINE/PubMed |
spelling | pubmed-20629362009-09-10 Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. Xie, X. Clausen, O. P. De Angelis, P. Boysen, M. Br J Cancer Research Article Using nucleolar organizer regions (NORs) as a proliferative marker and Bax expression as a marker for apoptosis, we have studied the individual and combined prognostic significance of these markers. Successive sections of diagnostic, formalin-fixed and paraffin-embedded specimens from 69 patients with T1-4 tumours were stained with a rabbit anti-human Bax polyclonal antibody and silver nitrate for visualization of NORs (AgNORs). After classification for staining intensity and the percentage of Bax expression, a final score resulting in four classes of increasing Bax expression was obtained. AgNOR counts were expressed as mean counts (mAgNOR) and the percentage of tumour nuclei with more than one AgNOR (pAgNOR>1). Both AgNOR parameters were grouped in three classes with increasing values. Low Bax scores correlated significantly with poor prognosis (P = 0.0106). For mAgNOR and pAgNOR>1, high values correlated with poor prognosis (P = 0.0185 and P = 0.0003 respectively). A combined parameter, for which the Bax score was subtracted from the AgNOR scores, appeared to be statistically stronger than the individual parameters (P < 0.0001). Both Bax expression and AgNOR scores, and in particular the combination of these parameters, appear to be strong prognostic markers in glottic squamous cell carcinomas. Nature Publishing Group|1 1998-07 /pmc/articles/PMC2062936/ /pubmed/9662258 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Research Article Xie, X. Clausen, O. P. De Angelis, P. Boysen, M. Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title | Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title_full | Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title_fullStr | Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title_full_unstemmed | Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title_short | Bax expression has prognostic significance that is enhanced when combined with AgNOR counts in glottic carcinomas. |
title_sort | bax expression has prognostic significance that is enhanced when combined with agnor counts in glottic carcinomas. |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2062936/ https://www.ncbi.nlm.nih.gov/pubmed/9662258 |
work_keys_str_mv | AT xiex baxexpressionhasprognosticsignificancethatisenhancedwhencombinedwithagnorcountsinglotticcarcinomas AT clausenop baxexpressionhasprognosticsignificancethatisenhancedwhencombinedwithagnorcountsinglotticcarcinomas AT deangelisp baxexpressionhasprognosticsignificancethatisenhancedwhencombinedwithagnorcountsinglotticcarcinomas AT boysenm baxexpressionhasprognosticsignificancethatisenhancedwhencombinedwithagnorcountsinglotticcarcinomas |